170798 ⎘
Detection or diagnosis of diseases Endocrine or metabolic disorders
Sub-classes:ASSAYS FOR LYSOSOMAL STORAGE DISEASES
#2METHOD FOR DETECTING LYSOSOMAL STORAGE DISEASE BIOMARKERS AND KITS FOR PERFORMING THE METHOD
#3METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE
#4BIOMARKER FOR DIAGNOSING CENTRAL PRECOCIOUS PUBERTY IN FEMALES AND USES THEREOF
#5BIOMARKERS OF LYSOSOMAL STORAGE DISEASE
#6COMPOSITIONS AND METHODS THAT PROMOTE HYPOXIA OR THE HYPOXIA RESPONSE FOR TREATMENT AND PREVENTION OF MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS DISORDERS
#7Saliva Uric Acid Test Strip Composition and Related Methods to lower elevated levels
#8HUMAN PITUITARY NEUROENDOCRINE TUMOR ORGANOIDS AND METHODS OF MAKING AND USING THE SAME
#9MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA
#10SYSTEMS AND METHODS FOR IMPROVED METABOLOMICS
#11Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases
#12SYSTEMS AND METHODS FOR PREDICTING RESPONSE TO ORAL MINOXIDIL FOR THE TREATMENT OF ANDROGENETIC ALOPECIA
#13Application of Organic Acids in Urine for Health Management
#14BIOMARKERS OF HIDDEN OBESITY FOR USE IN PREVENTATIVE HEALTHCARE
#15Biomarkers For Lysosomal Storage Diseases
#16MARKER FOR ACID SPHINGOMYELINASE DISORDERS AND USES THEREOF
#17DETECTION OF KDM1A LOSS OF ACTIVITY FOR DIAGNOSING ENDOCRINE DISORDERS
#18BROWN ADIPOCYTE PROGENITORS IN HUMAN SKELETAL MUSCLE
#19Methods and Compositions Relating to Microbial Treatment and Diagnosis of Disorders
#20METHOD FOR DIAGNOSING AND TREATING METABOLIC DISORDERS
#21DIFFERENTIAL DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME
#22SCREENING KIT AND DIAGNOSIS SYSTEM FOR PRIMARY ALDOSTERONISM
#23COMPOSITIONS AND METHODS FOR ORGANOID GENERATION AND DISEASE MODELING
#24BIOMARKERS COMPOSITION RELATED TO DIAGNOSIS AND PROGNOSIS OF IMMUNOGLOBULIN A NEPHROPATHY AND APPLICATION THEREOF
#25METHODS FOR TREATING INHERITED METABOLIC DISORDERS
#26Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)
#27METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DEVELOPING AN ANEMIA AND/OR A METABOLIC CONDITION RELATED TO THE NUTRITIONAL STATE AND/OR FLUID BALANCE OF THE BLOOD
#28MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
#29METHODS OF DETECTING AND USING BIOMARKERS FOR GLYCOGEN STORAGE DISEASES
#30TREATMENT OF, AND DIFFERENTIAL DIAGNOSIS BETWEEN, ACTH-DEPENDENT CUSHING'S SYNDROME AND ACTH-INDEPENDENT CUSHING'S SYNDROME
#31Measurement, Diagnosis, Treatment and Management of Metabolic Syndrome
#32SEROLOGIC ASSAY FOR SILENT BRAIN ISCHEMIA
#33Methods for Modulating Bile Acid Homeostasis and Treatment of Bile Acid Disorders and Diseases
#34Method for analyzing glycosaminoglycan
#35COMPOUNDS AND METHODS FOR THE DETECTION OF FABRY DISEASE
#36METHOD FOR MAKING A FINDING FOR THE FUNCTIONALITY OF AN ANOREXIGENIC SIGNAL PATH FOR A PATIENT
#37Detection and Treatment of Conditions Related to Luteinizing Hormone/Follicle-Stimulating Hormone (LH/FSH) Levels
#38COMPOSITIONS AND METHODS FOR DETECTING AUTOANTIBODIES
#39COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF METABOLIC DISEASES AND DISORDERS
#40METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE
#41Compositions and methods for organoid generation and disease modeling
#42Method for the diagnosis of Niemann-Pick disease
#43Methods for Treatment of Fabry Disease
#44TMA-formation inhibitor treatment for elevated TMA-containing compound diseases
#45PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FABRY DISEASE, CONTAINING TSP1 PROTEIN INHIBITOR AS ACTIVE INGREDIENT
#46Use of macimorelin in assessing growth hormone deficiency in children
#47Methods and compositions relating to microbial treatment and diagnosis of disorders
#48INTEGRATED DRUG DISCOVERY PLATFORM FOR INBORN ERROR OF METABOLISM DISORDERS
#49MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
#50Mass spectrometry assay for congenital adrenal hyperplasia
#51Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#52HSP70 PROTEIN LEVELS IN PBMC SAMPLES AS BIOMARKER FOR DISEASE
#53Methods of treating acid sphingomyelinase deficiency
#54METHODS OF DETECTING AMINO ACID DEFICIENCIES
#55PATIENT ASSESSMENT METHOD
#56Methods for identification, assessment, prevention, and treatment of metabolic disorders using PM20D1 and N-lipidated amino acids
#57COMPOSITIONS AND METHODS THAT PROMOTE HYPOXIA OR THE HYPOXIA RESPONSE FOR TREATMENT AND PREVENTION OF MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS DISORDERS
#58DIAGNOSTIC METHODS AND KITS
#59METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER
#60Method for presymptomatic diagnosis of coeliac disease and gluten sensitivity
#61METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS
#62Brown adipocyte progenitors in human skeletal muscle
#63NOVEL PHARMACOLOGICAL THERAPY FOR NEURONOPATHIC GAUCHER DISEASE
#64Methods and compositions relating to microbial treatment and diagnosis of disorders
#65Mass spectrometry assay for congenital adrenal hyperplasia
#66Methods and systems for the detection of 11-oxo androgens by LC-MS/MS
#67METHODS AND COMPOSITIONS FOR THE TREATMENT OF CUSHING'S SYNDROME USING 2S, 4R KETOCONAZOLE
#68KITS FOR DETECTION OF HEPCIDIN
#69Method for the Diagnosis of Metachromatic Leukodystrophy
#70Compositions and methods for diagnosing and treating peroxisomal diseases
#71METHOD OF DIAGNOSIS OF ADRENAL INSUFFICIENCY
#72Methods and compositions relating to microbial treatment and diagnosis of disorders
#73Methods and compositions relating to microbial treatment and diagnosis of disorders
#74Biomarkers of organic acidemias
#75METHODS FOR DIAGNOSING AND ASSESSING TREATMENT FOR CUSHING'S SYNDROME
#76Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#77Method for the diagnosis of Niemann-Pick disease
#78Mass spectrometry assay for congenital adrenal hyperplasia
#79SEROLOGIC ASSAY FOR SILENT BRAIN ISCHEMIA
#80Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptoms and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)
#81PHARMACEUTICAL COMPOSITION FOR INDUCING EXERCISE MIMETIC EFFECT
#82SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT
#83Tissue-specific exosomes as biomarkers
#84Methods for treatment of Fabry disease
#85Compositions and methods for treating lysosomal storage diseases and disorders
#86METHODS FOR PREVENTION AND TREATMENT OF CARDIOMETABOLIC SYNDROME AND COMPOSITIONS USED THEREIN
#87Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome
#88METHODS AND COMPOSITIONS FOR THE TREATMENT OF CUSHING'S SYNDROME USING 2S, 4R KETOCONAZOLE
#89Biological detection method for dioxins in serum, and diagnostic use therefor in metabolic syndrome and related conditions
#90FARBER DISEASE MARKERS AND USES THEREOF
#91Compounds and Methods to Measure Metabolic Function and Restore Normal Metabolic Function
#92Method For Quantifying Plasmalogens Using PLA1 Processing
#93Trimethylamine-containing compounds for diagnosis and prediction of disease
#94Compositions and methods for organoid generation and disease modeling
#95Methods for identifying and treating cachexia or pre-cachexia using an inhibitor of rage
#96MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
#97Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Liver Fibrosis
#98Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Cirrhosis
#99Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Nonalcoholic Fatty Liver Disease
#100Methods of therapeutic monitoring of nitrogen scavenging drugs
#101COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING METABOLIC SYNDROME, AND METHODS USING SAME
#102SYSTEMS, COMPOSITIONS, AND METHODS FOR TARGETED CHALLENGE AND IDENTIFICATION OF GUT MICROBIOTA
#103Methods and compositions relating to microbial treatment and diagnosis of disorders
#104METHODS AND COMPOSITIONS RELATING TO MICROBIAL TREATMENT AND DIAGNOSIS OF DISORDERS
#105Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome
#106Methods and compositions relating to microbial treatment and diagnosis of disorders
#107Methods and compositions relating to microbial treatment and diagnosis of disorders
#108Compositions and methods that promote hypoxia or the hypoxia response for treatment and prevention of mitochondrial dysfunction and oxidative stress disorders
#109COMPOSITIONS AND METHODS FOR INDUCING SATIETY AND TREATING NON-INSULIN DEPENDENT DIABETES MELLITUS, PRE-DIABETIC SYMPTOMS, INSULIN RESISTANCE AND RELATED DISEASE STATES AND CONDITIONS
#110Method for the Diagnosis of Niemann-Pick Disease Using a Biomarker
#111Agent for use in the case of fructose intolerance
#112METHODS AND COMPOSITIONS FOR THE TREATMENT OF CUSHING'S SYNDROME USING 2S, 4R KETOCONAZOLE
#113Method for separating the fraction bound to glycosaminoglycans and applications thereof
#114Methods for treatment of Fabry disease
#115Soluble MANF in pancreatic beta-cell disorders
#116Methods and compositions for treating metabolic imbalance in neurodegenerative disease
#117Compositions and methods for the treatment of fatty acid metabolism disorders
#118Methods for diagnosing and assessing treatment for Cushing's syndrome
#119Marker for acid sphingomyelinase disorders and uses thereof
#120Method for quantifying plasmalogens using PLA1 processing
#121Device and methods of using device for detection of hyperammonemia
#122LIPODOMIC BIOMARKERS OF METABOLIC DISEASES IN DAIRY COWS
#123Methods of therapeutic monitoring of nitrogen scavenging drugs
#124Methods of therapeutic monitoring of nitrogen scavenging drugs
#125Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
#126Methods for treatment of fabry disease
#127DIAGNOSTIC METHODS AND KITS
#128Methods of therapeutic monitoring of nitrogen scavenging drugs
#129Methods of therapeutic monitoring of nitrogen scavenging drugs
#130Methods of therapeutic monitoring of nitrogen scavenging drugs
#131Methods of therapeutic monitoring of nitrogen scavenging drugs
#132Methods of therapeutic monitoring of nitrogen scavenging drugs
#133Ferric ion detection method
#134Mass spectrometry assay for congenital adrenal hyperplasia
#135Methods for assaying palmitoyl protein thioesterase 1 and tripeptidyl peptidase activity in dried blood spots for detection of neuronal ceroid lipofuscinoses in newborns
#136Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#137Method for the diagnosis of Farber's disease
#138Methods of using compositions comprising variants of FGF19 polypeptides for treating primary biliary cirrhosis in a subject
#139Method for diagnosis of primary hyperaldosteronism
#140Device and methods of using device for detection of hyperammonemia
#141Methods for treating Cushing's syndrome
#142Method for the diagnosis of Niemann-Pick disease
#143Compositions and methods for the treatment of fatty acid metabolism disorders
#144Methods of therapeutic monitoring of nitrogen scavenging drugs
#145Methods for predicting glucoregulatory dysfunction via diacylglycerol fatty acid species concentrations
#146Dermatopontin as a therapeutic for metabolic disorders
#147Acyl-CoA dehydrogenases micro/nano enzyme assay
#148METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS
#149Methods of therapeutic monitoring of nitrogen scavenging drugs
#150Methods of therapeutic monitoring of nitrogen scavenging drugs
#151Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome
#152EXPRESSION AND FUNCTION OF GPR64/ADGRG2 IN ENDOCRINE SYSTEMS AND METHODS TO TARGET IT THERAPEUTICALLY
#153Pharmacological therapy for neuronopathic Gaucher disease
#154METHOD OF DIAGNOSING AND TREATING BRAIN ENDOTHELIAL INFLAMMATION RELATED DISEASE
#155Bile acid biomarkers for Niemann-Pick diseases, methods and uses therefor
#156METHODS AND COMPOSITIONS FOR THE TREATMENT OF CUSHING'S SYNDROME USING 2S, 4R KETOCONAZOLE
#157Compositions and methods for diagnosis and treatment of metabolic syndrome
#158Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptomes and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)
#159Drug for the treatment of cholesterol accumulation disorders
#160BIOMARKERS FOR ANDERSON-FABRY DISEASE
#161DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF AMINOACIDOPATHIES
#162G protein coupled receptor 85 and SREB3 knockout mice and uses thereof
#163Enzyme Assays on a Droplet Actuator
#164BIOMARKERS FOR SANFILIPPO SYNDROME AND USES THEREOF
#165Functionalized gold nanoparticles and methods thereof
#166ACYLCARNITINE COMPOSITION
#167Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment
#168METHODS FOR TREATING UREA CYCLE DISORDERS TO PREVENT HYPERAMMONEMIC CRISES BY CONTROLLING BLOOD AMMONIA LEVELS
#169C1q-ADIPONECTIN COMPLEX AND USE THEREOF
#170Rapid small volume detection of blood ammonia
#171Methods useful for vitamin D deficiency and related disorders
#172Methods for treatment of Fabry disease
#173Rapid small volume detection of blood ammonia
#174Methods and compositions relating to microbial treatment and diagnosis of disorders
#175GDF15 AS BIOMARKER FOR DIAGNOSING MITOCHONDRIAL DISEASES
#176Biomarkers of mineralocorticoid receptor activation
#177Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA
#178Compositions and methods for diagnosis and treatment of metabolic syndrome
#179Optimizing mifepristone levels for cushing's patients
#180Biomarkers for detecting pre-cachexia or cachexia and methods of treatment thereof
#181Brown Adipocyte Progenitors in Human Skeletal Muscle
#182METHODS FOR PREVENTION AND TREATMENT OF CARDIOMETABOLIC SYNDROME AND COMPOSITIONS USED THEREIN
#183Methods of treating metabolic disorders
#184Method for diagnosis of primary hyperaldosteronism
#185Assessing renal structural alterations and outcomes
#186Methods of using variants of FGF19 polypeptides for the treatment of cancer
#187Compositions and Methods for Evaluating Metabolic Syndrome and Related Diseases
#188Device and methods of using device for detection of hyperammonemia
#189Methods and compositions relating to microbial treatment and diagnosis of disorders
#190Diagnosis and treatment of incipient diabetes
#191Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#192METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS
#193METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS
#194Method for detecting risk factor for metabolic syndrome or hyperferritinemia
#195Method for Monitoring Heptadecanoic Acid in Human and Animal Samples
#196Method for treating metabolic syndrome
#197Heptadecanoic acid supplement to human diet
#198Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome
#199Biomarkers for cardiovascular diseases and methods using the same
#200Device and methods of using device for detection of aminoacidopathies
#201Compositions and methods for the treatment of fatty acid metabolism disorders
#202Marker for acid sphingomyelinase disorders and uses thereof
#203Method for the diagnosis of Niemann-Pick disease
#204Methods relating to testing for lysosomal storage disorders
#205Methods of using compositions comprising variants and fusions of FGF19 polypeptides for treatment of nonalcoholic steatohepatitis
#206Measurement of FGF21 as a biomarker of fructose metabolism
#207METHYLCITRATE ANALYSIS IN DRIED BLOOD SPOTS
#208HYPOSIALYLATION DISORDERS
#209Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
#210DIAGNOSIS AND THERAPY OF CHRONIC INFLAMMATION-INDUCED DISORDERS
#211Methods for assaying alpha-L-iduronidase enzymatic activity
#212Method of screening compounds for the treatment of diabetes
#213Analysis of a panel of cerebrotendinous xanthomatosis biomarkers using site specific derivation and LC/MS/MS workflow
#214Method for the diagnosis of metachromatic leukodystrophy
#215Arginine vasopressin pro-hormone as predictive biomarker for diabetes
#216Mass spectrometry assay for congenital adrenal hyperplasia
#217ACYL-COA DEHYDROGENASE ASSAYS
#218Methods for treatment of Fabry disease
#219Soluble MANF in pancreatic β-cell disorders
#220Enzyme assays on a droplet actuator
#221Marker peptide for determining risk of developing metabolic syndrome, and use thereof
#222Methods useful for vitamin D deficiency and related disorders
#223Methods for measuring fat digestibility and uses thereof
#224PC-O 40:1 as a biomarker for healthy aging
#225URINARY BIOMARKERS OF RENAL AND MITOCHONDRIAL DYSFUNCTION
#226C1q-ADIPONECTIN COMPLEX AND USE THEREOF
#227ASSAYS FOR DETECTION OF GLYCOSAMINOGLYCANS
#228MEANS AND METHODS FOR ASSESSING AN ENDOCRINE DISEASE OR DISORDER
#229Biomarkers for insulin resistance and methods using the same
#230PERIPHERIN-SPECIFIC AUTOANTIBODIES AS A MARKER FOR NEUROLOGICAL AND ENDOCRINOLOGICAL DISEASE
#231Methods of selecting and treating subjects with low-grade inflammation and metabolic disorders
#232MEX3C REGULATION AND TARGET TO CONTROL OBESITY AND DIABETES
#233Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
#234Devices for performing colorimetric assay with plucked human hair
#235Method of treating a metabolic disorder induced by obesity in a subject in need thereof by administering MK2/3 inhibitors
#236Method for the diagnosis of Niemann-Pick disease
#237Hyposialylation disorders
#238Method of diagnosing Sjogren's disease
#239Mass spectrometry assay for congenital adrenal hyperplasia
#240Assay for B-galactosidase activity
#241System and method for diagnosis and treatment
#242Methods for treating metabolic syndrome with Cthrc1 polypeptide
#243Solid support and method of enhancing the recovery of biological material therefrom
#244Inhibition of delta-6 desaturase for the treatment of cardiometabolic disease
#245Brown adipocyte progenitors in human skeletal muscle
#246Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#247Agent for use in the case of fructose intolerance
#248BIOMARKERS FOR SANFILIPPO SYNDROME AND USES THEREOF
#249Methods of therapeutic monitoring of nitrogen scavenging
#250Method of diagnosing Sjogren's disease
#251PERIPHERIN-SPECIFIC AUTOANTIBODIES AS A MARKER FOR NEUROLOGICAL AND ENDOCRINOLOGICAL DISEASE
#252Compositions, kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
#253Detecting succinylacetone
#254DETECTING ISOMERS USING DIFFERENTIAL DERIVATIZATION MASS SPECTROMETRY
#255COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF MITOCHONDRIAL DISEASES
#256Mass spectrometry assay for congenital adrenal hyperplasia
#257Methods for treatment of Fabry disease
#258Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#259Biomarkers for monitoring insulin resistance and methods using the same
#260System and method for diagnosis and treatment
#261Electronic methods for the detection of analytes
#262DETECTION OF GLOBOTRIAOSYLCERAMIDE (GLC) IN HUMAN URINE SAMPLES USING AN ANTIBODY SANDWICH
#263Trimethylamine-containing compounds for diagnosis and prediction of disease
#264IN VITRO METHOD FOR DETECTING GP91PHOX AS A MARKER OF OXIDATIVE STRESS
#265Method of hydrolyzing an enzymatic substrate
#266METHODS AND MATERIALS FOR DIAGNOSING LIGHT CHAIN AMYLOIDOSIS
#267COMPOSITION AND MULTIPLEX ASSAYS FOR MEASURING BIOLOGICAL MEDIATORS OF PHYSIOLOGICAL HEALTH
#268Simultaneous detection of metabolic enzyme activity and metabolite levels
#269Systems and methods for predicting response to minoxidil for the treatment of androgenetic alopecia
#270Methods for assaying α-L-iduronidase enzymatic activity
#271ASSAY FOR DETECTION OF ADRENAL TUMOUR
#272OPTIMIZING ERYTHROPOIETIN THERAPY
#273Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases
#274IN VITRO-METHOD FOR THE DIAGNOSIS, PROGNOSIS, MONITORING AND THERAPY FOLLOW-UP OF DISORDERS ASSOCIATED WITH THE METABOLIC SYNDROME, A CARDIOVASCULAR DISEASE AND/OR INSULIN RESISTANCE
#275Arginine vasopressin pro-hormone as predictive biomarker for diabetes
#276COMPOUNDS AND METHODS TO MEASURE METABOLIC FUNCTION AND RESTORE NORMAL METABOLIC FUNCTION
#277Compositions and methods for treating insulin resistance and non-insulin dependent diabetes mellitus (type II diabetes)
#278Methods of activating a melanocortin-4 receptor pathway in obese subjects
#279Biomarkers of Mineralocorticoid Receptor Activation
#280MEX3C REGULATION AND TARGET TO CONTROL OBESITY AND DIABETES
#281Method of identifying a compound for the treatment or prevention of obesity
#282Fatty acid C16: 1N7-palmitoleate a lipokine and biomarker for metabolic status
#283METHODS FOR DETERMINING LEVELS OF 1,25 DIHYDROXY VITAMIN D2 AND D3
#284Detecting succinylacetone
#285Detecting leucine and its isomers using differential esterification mass spectrometry
#286Categorically ranking animals for feed efficiency
#287Biomarker for Mitochondrial Toxicity Associated with Phospholipidosis
#288NATRIURETIC PEPTIDES AND ADIPONECTIN IN SUBJECTS WITH A METABOLIC SYNDROME
#289METHOD TO PREDICT RESPONSE TO PHARMACOLOGICAL CHAPERONE TREATMENT OF DISEASES
#290Brown adipocyte progenitors in human skeletal muscle and methods for identifying differentiation agents therefor
#291METHODS FOR PREDICTING WEIGHT LOSS SUCCESS
#292METHOD OF PREDICTING DRUG-INDUCED PHOSPHOLIPIDOSIS
#293DIAGNOSTIC OF PRE-SYMPTOMATIC METABOLIC SYNDROME
#294ASSAYS FOR DIAGNOSING AND EVALUATING TREATMENT OPTIONS FOR FABRY DISEASE
#295Measuring multiple analytes over a broad range of concentrations using optical diffraction
#296Liquid chromatography-mass spectrometry methods for multiplexed detection and quantitation of free amino acids
#297Methods of distinguishing between glutamine formed by cataplerosis or proteolysis
#298Methods for Diagnosing and Treating Iron Dysregulation
#299Electronic methods for the detection of analytes
#300Methods useful for vitamin D deficiency and related disorders